Concepts (621)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with JASON ROBERT WESTIN's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that JASON ROBERT WESTIN has written about over time.
PrednisoneHodgkin DiseaseHematopoietic Stem Cell TransplantationHumansAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideLymphomaLymphoma, Non-HodgkinRituximabLymphoma, Mantle-CellLymphoma, FollicularLymphoma, Large B-Cell, DiffuseLymphoma, B-Cell, Marginal ZoneReceptors, Antigen, T-CellLymphoma, B-CellImmunotherapy, AdoptiveBiological ProductsAntigens, CD19
To see the data from this visualization as text,
click here.
Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
Prednisone | 29 | 1977 | 2023 | September 2007 |
Hodgkin Disease | 12 | 1973 | 2020 | January 2011 |
Hematopoietic Stem Cell Transplantation | 18 | 1998 | 2023 | May 2013 |
Humans | 235 | 1970 | 2024 | July 2013 |
Antineoplastic Combined Chemotherapy Protocols | 78 | 1990 | 2023 | December 2013 |
Cyclophosphamide | 26 | 1970 | 2023 | January 2015 |
Lymphoma | 9 | 2012 | 2023 | January 2017 |
Lymphoma, Non-Hodgkin | 17 | 1986 | 2024 | December 2017 |
Rituximab | 38 | 2009 | 2023 | February 2018 |
Lymphoma, Mantle-Cell | 12 | 2015 | 2024 | February 2019 |
Lymphoma, Follicular | 15 | 2013 | 2023 | October 2019 |
Lymphoma, Large B-Cell, Diffuse | 84 | 2009 | 2024 | February 2020 |
Lymphoma, B-Cell, Marginal Zone | 10 | 2017 | 2024 | May 2020 |
Receptors, Antigen, T-Cell | 14 | 2017 | 2024 | November 2020 |
Lymphoma, B-Cell | 15 | 2014 | 2024 | December 2020 |
Immunotherapy, Adoptive | 44 | 2017 | 2024 | February 2022 |
Biological Products | 14 | 2020 | 2024 | June 2022 |
Antigens, CD19 | 25 | 2017 | 2024 | July 2022 |
To return to the timeline,
click here.